R, R., K, B., S, M., W, F., JE, A., J, J., . . . V, S. (2022). Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use. The New England journal of medicine, 386(15), 1477. https://doi.org/10.1056/NEJMc2120219
Chicago Style (17th ed.) CitationR, Rockett, et al. "Resistance Mutations in SARS-CoV-2 Delta Variant After Sotrovimab Use." The New England Journal of Medicine 386, no. 15 (2022): 1477. https://doi.org/10.1056/NEJMc2120219.
MLA (9th ed.) CitationR, Rockett, et al. "Resistance Mutations in SARS-CoV-2 Delta Variant After Sotrovimab Use." The New England Journal of Medicine, vol. 386, no. 15, 2022, p. 1477, https://doi.org/10.1056/NEJMc2120219.
Warning: These citations may not always be 100% accurate.